BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer

Cancer

Volumn 115, Issue 10, 2009, Pages 2222-2233

  Hall, Michael J ^a,b   Reid, Julia E ^c   Burbidge, Lynn A ^c   Pruss, Dmitry ^c   Deffenbaugh, Amie M ^c   Frye, Cynthia ^c   Wenstrup, Richard J ^c   Ward, Brian E ^d   Scholl, Thomas A ^e   Noll, Walter W ^c  

^a Division of Hematology/Oncology and Familial Risk Assessment Program   (United States)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^c Utah   (United States)

^d DNAR Inc   (United States)

^e GENZYME CORPORATION   (United States)

Author keywords

BRCA1; BRCA2; Ethnicity; Genetic testing; Race

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; BREAST CANCER; BREAST CANCER GENE 1; BREAST CANCER GENE 2; CANCER RISK; CROSS-SECTIONAL STUDY; DNA SEQUENCE; ETHNIC DIFFERENCE; ETHNICITY; EUROPEAN AMERICAN; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; WESTERN EUROPE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY HEALTH; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; LATIN AMERICA; MIDDLE AGED; MIDDLE EAST; MINORITY HEALTH; MUTATION;

EID: 65649112508     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24200     Document Type: Article

References (56)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics 2007. CA Cancer J Clin. 2007;57:43-66.
2. Claus EB, Schildkraut JM, Thompson WD, Risch NJ. The genetic attributable risk of breast and ovarian cancer. Cancer. 1996;77:2318-2324.
3. Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol. 2005;23:276-292.
4. Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004;22:1055-1062.
5. Pal T, Permuth-Wey J, Holtje T, Sutphen R. BRCA1 and BRCA2 mutations in a study of African American breast cancer patients. Cancer Epidemiol Biomarkers Prev. 2004;13(11 pt 1):1683-1686.
6. Hartmann LC, Sellers TA, Schaid DJ, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2003;93:1586-1587.
7. Eisen A, Lubinski J, Klijn J, et al. Breast cancer risk following bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. J Clin Oncol. 2005;23:7491-7496.
8. Rebbeck TR, Lynch HT, Neuhausen SL, et al. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. N Engl J Med. 2002;346:616-622.
9. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66-71. (Pubitemid 24345325)
10. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:789-792. (Pubitemid 26004412)
11. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet. 1994;343:692-695.
12. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997;336:1401-1408. (Pubitemid 27208598)
13. Metcalfe K, Lynch HT, Ghadirian P, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2004;22:2328-2335. (Pubitemid 41115389)
14. Verhoog LC, Brekelmans CTM, Seynaeve C, et al. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet. 1998;351:316-321. (Pubitemid 28052696)
15. Whittemore AS, Gong G, Itnyre J. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from 3 U.S. population-based case-control studies of ovarian cancer. Am J Hum Genet. 1997;60:496-504.
16. Szabo CI, King MC. Population genetics of BRCA1 and BRCA2. Am J Hum Genet. 1997;60:1013-1020.
17. Leide A, Narod SA. Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat. 2002;20:413-424.
18. Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F, Whitfield-Broome C. Breast cancer genetics in African Americans. Cancer. 2003;97(suppl 1):236-245.
19. John E, Miron A, Gong G, et al. Prevalence of pathogenic BRCA1 mutation carriers in 5 racial/ethnic groups. JAMA. 2007;298:2869-2876.
20. Haffty BG, Silber A, Matloff E, Chung J, Lannin D. Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women. J Med Genet. 2006;43:133-137.
21. King MC, Marks JH, Mandell JB; New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302:643-646.
22. Oddoux C, Struewing JP, Clayton CM, et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet. 1996;14:188-190. (Pubitemid 26338802)
23. Nanda R, Schumm LP, Cummings S, et al. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA. 2005;294:1925-1933.
24. Frank TS, Deffenbaugh AM, Reid JE, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol. 2002;20:1480-1490.
25. Hendrickson BC, Judkins T, Ward BD, et al. Prevalence of 5 previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families. Genes Chromosomes Cancer. 2005;43:309-313. (Pubitemid 40726876)
26. Beaudet AL, Tsui LCA. suggested nomenclature for designating mutations. Hum Mutat. 1993;2:245-248. (Pubitemid 23231498)
27. Goldgar DE, Easton DF, Deffenbaugh AM, et al. Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet. 2004;75:535-544.
28. Judkins T, Hendrickson BC, Deffenbaugh AM, et al. Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations. Cancer Res. 2005;65:10096-10103. (Pubitemid 41541492)
29. Weitzel JN, Lagos V, Blazer KR, et al. Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev. 2005;14:1666-1671. (Pubitemid 40995077)
30. US Census Bureau. Overview of Race and Hispanic Ethnicity: 2000. Available at: http://www.census.gov/prod/2001pubs/c2kbr01-1.pdf Accessed September 1, 2008.
31. National Cancer Institute. Surveillance, Epidemiology, and End Results. Cancer Stat Fact Sheet: Breast. Available at: http://seer.cancer.gov/statfacts/ html/breast.html Accessed September 1, 2008.
32. National Cancer Institute. Surveillance, Epidemiology, and End Results. Cancer Stat Fact Sheet: Ovary. Available at: http://seer.cancer.gov/statfacts/ html/ovary.html Accessed September 1, 2008.
33. Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 2006;56:168-183.
34. Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005;97:439-448.
35. Murtaugh MA, Sweeney C, Giuliano AR, et al. Diet patterns and breast cancer risk in Hispanic and non-Hispanic white women: the Four-Corners Breast Cancer Study. Am J Clin Nutr. 2008;87:978-984.
36. Wu AH. Diet and breast carcinoma in multiethnic populations. Cancer. 2000;88(5 suppl):1239-1244.
37. Slattery ML, Sweeney C, Edwards S, et al. Body size, weight change, fat distribution, and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat. 2007;102:85-101.
38. Ogden CL, Carrol MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555.
39. John EM, Horn-Ross PL, Koo J. Lifetime physical activity and breast cancer risk in a multi-ethnic population: the San Francisco Bay Area Breast Cancer Study. Cancer Epidemiol Biomarkers Prev. 2003;12:1143-1152.
40. Setiawan VW, Haiman CA, Stanczyk FZ, et al. Racial/ethnic differences in post-menopausal endogenous hormones: the multi-ethnic cohort study. Cancer Epidemiol Biomarkers Prev. 2006;15:1849-1855.
41. Pinheiro SP, Holmes MD, Pollak MN, Barbieri RL, Hankinson SE. Racial differences in premenopausal endogenous hormones. Cancer Epidemiol Biomarkers Prev. 2005;14:2147-2153.
42. Hausauer AK, Keegan THM, Chang ET, Clarke CA. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype [serial online]. Breast Cancer Res. 2007;9:R90.
43. Reis-Filho JS, Tutt AN. Triple negative tumours: a critical review. Histopathology. 2008;52:108-118.
44. Morris GJ, Naidu S, Topham AK, et al. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared to the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Cancer. 2007;110:876-884.
45. Armstrong K, Micco E, Carney A, Stopfer J, Putt M. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA. 2005;293:1729-1736.
46. Weissman JS, Schneider EC. Social disparities in cancer: lessons from a multi-disciplinary workshop. Cancer Causes Control. 2005;16:71-74.
47. National Center for Health Statistics. National Health Interview Survey 2000. In: Pastor PN, Makuc DM, Reuben C, Hia H, eds. Chartbook on Trends of Health of Americans, Health, United States, 2000. DHSS Publication No. 1232-1. Hyattsville, Md: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2002;97-99.
48. Wideroff L, Vadaparampil ST, Breen N, et al. Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey. Commun Genet. 2003;6:147-156. (Pubitemid 38916113)
49. Matthews AK, Cummings S, Thompson S, et al. Genetic testing of African Americans for susceptibility to inherited cancers. J Psychosoc Oncol. 2000;18:1-13.
50. Peters N, Rose A, Armstrong K. The association between race and attitudes about predictive genetic testing. Cancer Epidemiol Biomarkers Prev. 2004;13:361-365.
51. Lerman C, Hughes S, Benkendorf JL, et al. Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev. 1999;8:361-367. (Pubitemid 29193891)
52. Neuhausen SL, Mazoyer S, Friedman L, et al. Haplotype and phenotype analysis of 6 recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet. 1996;58:271-280.
53. Olopade OI, Fackethal JD, Dunston G, Tainsky MA, Collins F, Whitfield-Broome C. Breast cancer genetics in African Americans. Cancer. 2003;97(1 suppl):236-245.
54. Judkins T, Hendrickson BC, Deffenbaugh AM, Scholl T. Single nucleotide polymorphisms in clinical genetic testing: the characterization of the clinical significance of genetic variants and their application in clinical research for BRCA1. Mutat Res. 2005;573:168-179.
55. Kang HH, Williams R, Leary J; kConFab Investigators, et al. Evaluation of models to predict BRCA germline mutations. Br J Cancer. 2006;95:914-920.
56. Wenstrup R, Judkins T, Eliason K, et al. Molecular genetic testing for large genomic deletion and duplication mutations in the BRCA1 and BRCA2 genes for hereditary breast and ovarian cancer [abstract]. 2007 ASCO Annual Meeting Proceedings. J Clin Oncol. 2007;25(18S). Abstract 10513.